Quest Diagnostics layoffs, on the record
Every job cut, severance charge and restructuring Quest Diagnostics reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from approximately 48,000 to nearly 57,000.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | approximately 48,000 | December 31, 2023 |
| 10-K for 2024 | approximately 56,000 | December 31, 2024 |
| 10-K for 2025 | nearly 57,000 | December 31, 2025 |
Job cuts, severance and restructuring
Our summaryCompany pursued the multi-year Invigorate program, which includes structured plans to drive savings and improve productivity across the value chain.
Word for word“The Company is engaged in a multi-year program called Invigorate, which includes structured plans to drive savings and improve productivity across the value chain, including in such areas as patient services, logistics and laboratory operations, revenue services, information technology and procurement.” 10-K for 2023
Our summaryCompany incurred restructuring and integration charges tied to the Invigorate program and other restructuring activities, including employee separation costs.
Word for word“For the year ended December 31, 2023, we incurred $43 million of pre-tax charges in connection with our Invigorate program and other restructuring activities, including $25 million of employee separation costs, with the remainder primarily consisting of integration costs.” 10-K for 2023
Our summaryCompany recorded pre-tax charges primarily associated with workforce reductions and integration costs from further restructuring.
Word for word“pre-tax charges of $43 million ($16 million recorded in cost of services and $27 million recorded in selling, general and administrative expenses), or $0.29 per diluted share, primarily associated with workforce reductions and integration costs incurred in connection with further restructuring and integrating our business; and” 10-K for 2023
Our summaryCompany recorded employee separation costs and an asset impairment charge from the shutdown of a business within total restructuring and impairment charges, with the separation costs tied to workforce reduction initiatives.
Word for word“The restructuring charges incurred for the years ended December 31, 2023, 2022 and 2021 were partially associated with various workforce reduction initiatives as the Company continued to restructure its organization.” 10-K for 2023
Our summaryCompany recorded restructuring charges associated with workforce reduction initiatives in the prior year, including employee separation costs.
Word for word“pre-tax charges of $88 million ($32 million recorded in cost of services and $56 million recorded in selling, general and administrative expenses), or $0.56 per diluted share, primarily associated with workforce reductions, systems conversions and integration incurred in connection with further restructuring and integrating our business;” 10-K for 2023
Our summaryCompany recorded employee separation costs in the earliest year presented, associated with workforce reductions.
Word for word“Employee separation costs $ 25 $ 55 $ 11 Facility-related costs — — 1 Asset impairment charges 29 14 — Total restructuring and impairment charges $ 54 $ 69 $ 12 The restructuring charges incurred for the years ended December 31, 2023, 2022 and 2021 were partially associated with various workforce reduction initiatives as the Company continued to restructure its organization.” 10-K for 2023
Our summaryCompany incurred restructuring and integration charges under its multi-year Invigorate program, including employee separation costs.
Word for word“For the year ended December 31, 2024, we incurred $62 million of pre-tax charges in connection with restructuring and integration activities, including $28 million of employee separation costs, with the remainder including integration costs.” 10-K for 2024
Our summaryCompany recorded pre-tax net charges primarily tied to workforce reductions and integration costs from further restructuring.
Word for word“Results for the year ended December 31, 2024 were affected by certain items that on a net basis decreased diluted earnings per share by $1.24 as follows: • pre-tax amortization expense of $127 million recorded in amortization of intangible assets or $0.84 per diluted share; • pre-tax net charges of $62 million ($27 million recorded in cost of services and $37 million recorded in selling, general and administrative expenses, partially offset by a $2 million gain recorded in other operating expense, net), or $0.42 per diluted share, primarily associated with workforce reductions and integration costs incurred in connection with further restructuring and integrating our business;” 10-K for 2024
Our summaryCompany recorded pre-tax charges primarily tied to workforce reductions and integration costs from further restructuring.
Word for word“• pre-tax charges of $43 million ($16 million recorded in cost of services and $27 million recorded in selling, general and administrative expenses), or $0.29 per diluted share, primarily associated with workforce reductions and integration costs incurred in connection with further restructuring and integrating our business; and” 10-K for 2024
Our summaryQuest Diagnostics recorded pre-tax charges for restructuring and integration activities under its Invigorate program, including employee separation costs.
Word for word“For the year ended December 31, 2025, we incurred $53 million of pre-tax charges in connection with restructuring and integration activities, including $28 million of employee separation costs, with the remainder including integration costs.” 10-K for 2025
| Fiscal year ended | Restructuring charges | Cash paid for restructuring |
|---|---|---|
| 2016-12-31 | $11 million | $21 million |
| 2017-12-31 | $30 million | $17 million |
| 2018-12-31 | $49 million | $33 million |
| 2019-12-31 | −$3 million | $25 million |
| 2020-12-31 | $14 million | $16 million |
| 2021-12-31 | $13 million | $13 million |
| 2022-12-31 | $55 million | $18 million |
Quest Diagnostics has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Quest Diagnostics’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-26. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.